Wallace Chemicals Expected EPS of 66 Cents
Summary
Wali Chemical is expected to announce an EPS of 66 cents on May 8 for the period ending March 31, 2025. Currently, the sole analyst rating is ‘sell,’ and the average earnings forecast has remained unchanged over the past three months. Wall Street’s 12-month median price target for Wali Chemical is $20.00, which is above its last closing price of $17.59. Reuters
Impact Analysis
Business Overview Analysis: Wali Chemical operates in the chemical industry with core revenue streams likely derived from product manufacturing and sales. Given the analyst’s ‘sell’ rating, the company might be facing challenges in competitive positioning or market demand. The unchanged earnings forecast over three months indicates stable expectations but possibly lacks growth momentum. Reuters+ 2 Recent significant events include institutional investments from firms like Jacob Levy Equity Management Inc., indicating possible market confidence despite the ‘sell’ rating. Market Beat
Financial Statement Analysis:
- Income Statement: Wali Chemical’s expected EPS of 66 cents suggests its profitability levels, but the sole ‘sell’ rating indicates potential issues with revenue growth or margin trends not aligning with market expectations.
- Balance Sheet: The investment activities by various asset management firms suggest a stable asset quality or promising future outlook.
- Cash Flow: The investments highlight an influx of capital, potentially for operational needs or strategic expansion.
- Key Financial Ratios: Without explicit figures, assumptions can be made that profitability metrics may be under pressure given the analyst rating, while liquidity and solvency appear adequate given external investments.
Overall, Wali Chemical’s valuation is modest with potential upside if market conditions or internal strategies improve. Risks involve analyst skepticism and market performance, while opportunities include leveraging institutional investments for growth. Reuters
